CEO SUMMARY: In the final entry of our artificial intelligence series, the co-founders of Sample Healthcare discuss how clinical labs can evaluate AI vendors effectively, with an emphasis on assessing technical credentials and quick proofs of concept. Armed with the right information, labs can perform a successful AI evaluation that explores phased rollout and end-to-end […]
AI Hype in Labs: 6 Tips to Sniff Out the BS
Experts offer subtle questions for clinical labs to ask vendors about the functionality of AI products
- By Scott Wallask
- > From the Volume XXXII, No. 11 - August 4, 2025 Issue
- Tags: Aash Jain, Adaptive Biotechnologies, AI, Ankit Ranjan PhD, artificial intelligence, executive war college, FDA, Food and Drug Administration, G2 Intelligence, ivd/lab informatics, LinkedIn, live data, molecular diagnostics, phased deployment, POC, proofs of concept, protected health information, Sample Healthcare, synthetic data, the dark report, Today’s Clinical Lab, Y Combinator
